Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
AstraZeneca
Daiichi Sankyo
Cipla
Merck
Fish and Richardson

Generated: March 22, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050684

« Back to Dashboard

NDA 050684 describes ZOSYN, which is a drug marketed by Wyeth Pharms and is included in two NDAs. It is available from one supplier. There are four patents protecting this drug and two Paragraph IV challenges. Additional details are available on the ZOSYN profile page.

The generic ingredient in ZOSYN is piperacillin sodium; tazobactam sodium. There are sixteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the piperacillin sodium; tazobactam sodium profile page.
Summary for 050684
Tradename:ZOSYN
Applicant:Wyeth Pharms
Ingredient:piperacillin sodium; tazobactam sodium
Patents:3
Pharmacology for NDA: 050684
Mechanism of Actionbeta Lactamase Inhibitors
Suppliers and Packaging for NDA: 050684
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZOSYN piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050684 NDA Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. 0206-8852 0206-8852-16 10 VIAL, SINGLE-USE in 1 CARTON (0206-8852-16) > 10 mL in 1 VIAL, SINGLE-USE (0206-8852-08)
ZOSYN piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050684 NDA Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. 0206-8854 0206-8854-16 10 VIAL, SINGLE-USE in 1 CARTON (0206-8854-16) > 15 mL in 1 VIAL, SINGLE-USE (0206-8854-08)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL
Approval Date:Oct 22, 1993TE:APRLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Apr 14, 2023Product Flag?YSubstance Flag?Delist Request?
Patented Use:METHOD OF TREATING BACTERIAL INFECTIONS
Patent:➤ Try a Free TrialPatent Expiration:Apr 14, 2023Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:Apr 14, 2023Product Flag?YSubstance Flag?Delist Request?
Patented Use:METHOD OF TREATING BACTERIAL INFECTIONS

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Queensland Health
Deloitte
Farmers Insurance
Chinese Patent Office
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.